EBITDA for the fiscal year ended June 30, 2007 was $9.7 million, a 57.8 percent decrease, as compared to $23.0 million for the same period last year. EBITDA before stock-based compensation expense for the fiscal year ended June 30, 2007 was $13.5 million as compared to $26.2 million for the same period last year, a 48.5 percent decrease. EBITDA per adjusted prescription decreased to $0.39 during the fiscal year ended June 30, 2007 from $0.69 during the same period last year.
Net loss available to common stockholders for the fiscal year ended June 30, 2007 was $6.0 million, or ($1.10) per basic and diluted share, as compared to net income available to common stockholders of $3.6 million, or $0.70 per basic share and $0.67 per diluted share for the same period last year. For the fiscal year ended June 30, 2007, the Company's weighted-average number of diluted shares outstanding approximated 5.5 million shares, as compared to 5.3 million shares for the same period last year. The calculation for the fiscal years ended June 30, 2007 and 2006 does not assume the conversion of approximately 7.0 million shares of redeemable convertible preferred stock as they are anti-dilutive.
Fiscal 2008 Financial Outlook
Due to NMHC's on-going review of its infrastructure, service offerings and customer base, the Company at this time is not providing fiscal 2008 financial guidance. When NMHC determines it is appropriate, the Company intends to provide the market with an update.
Conference Call
Management will host a conference call tomorrow, September 11th, to
discuss their 2007 fiscal fourth quarter and full year results at 8:30 a.m.
ET. To listen to the call, please dial 866-800-8649 (U.S. callers) or
617-614- 2703 (international calle
'/>"/>
| SOURCE National Medical Health Card Systems, Inc. Copyright©2007 PR Newswire. All rights reserved |